Ophthalmic Solutions - Therapeutic use
Research News and Information

Sunday, November 22, 2009

Freeze-dried liposomes as potential carriers for ocular administration of cytochrome c against selenite cataract formation.

30 Aug 2009 OBJECTIVES: In this study, the preparation, stability and anti-cataract effect of cationic freeze-dried liposomes containing cytochrome c, along with nicotinamide and adenosine, are described. METHODS: Cytochrome c-loaded cationic liposomes (CC-L) ... Read more...

Use of eye shields and eye lubricants among oculoplastic and Mohs surgeons: a survey.

30 Aug 2009 BACKGROUND: Eye shields and lubricants are recommended for use in the eye during periorbital surgery to prevent injury to the globe. Nonetheless, data regarding their use is sparse, and no study to date has examined the prevalence of their usage and ... Read more...

Antibiotic therapy for trachoma.

30 Jul 2009 Trachoma, a major cause of blindness in some of the world's poorest countries, results from repeated or chronic eye infections with Chlamydia ... Read more...

Latest indexed articles for 'Ophthalmic Solutions - Therapeutic use'

These are the very latest articles for this heading:

• Freeze-dried liposomes as potential carriers for ocular administration of cytochrome c against selenite cataract formation. 30 Aug 2009
• The steroid controversy in bacterial keratitis. 30 Aug 2009
• Use of eye shields and eye lubricants among oculoplastic and Mohs surgeons: a survey. 30 Aug 2009
• Antibiotic therapy for trachoma. 30 Jul 2009
• Nepafenac: new drug. After cataract surgery: just another NSAID eye drop. No better than other NSAID eye drops, and less convenient to use. 30 Jul 2009
• Dry eye in 2008. 29 Jun 2009
• Pain management during retinopathy of prematurity eye examinations: a systematic review. 30 May 2009
• Latisse: empirical discovery yields treatment for sparse eyelashes. 30 May 2009
• Surgery for glaucoma: know your options. 30 May 2009
• Glaucoma and dry eye. 30 May 2009
• Prospective open-label study of the administration of two-percent voriconazole eye drops. 9 May 2009
• [Current methods for treating the dry eye syndrome] 29 Apr 2009
• Safety of petroleum-based eye lubricants. 29 Apr 2009
• Topical ophthalmic cyclosporine: pharmacology and clinical uses. 29 Apr 2009
• Clinical efficacy of a Ginkgo biloba extract in the topical treatment of allergic conjunctivitis. 29 Apr 2009
• Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment. 30 Mar 2009
• Congenital alacrima in a patient with blepharophimosis syndrome. 27 Feb 2009
• Ophthalmic drug delivery: development and regulatory considerations. 16 Feb 2009
• [Facial palsy: diagnosis and management by primary care physicians] 26 Jan 2009
• [Antiglaucoma drops--with or without preservatives] 30 Dec 2008

See a longer list of these articles.

Technical information about 'Ophthalmic Solutions'

Definition: Sterile solutions, essentially free from foreign particles and suitably compounded and dispensed, for instillation into the eye. It does not include solutions for cleaning eyeglasses or CONTACT LENS SOLUTIONS. (From Dorland, 27th ed)

Registry Number: 0

Descriptor UI: D009883

Alternative terms: Ophthalmic Solutions; Solutions, Ophthalmic; Eyedrops; Eye Drops; Drops, Eye; Tears, Artificial; Artificial Tears;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; chemical synthesis; classification; diagnostic use; economics; history; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; chemistry; contraindications;

Tree Number: D26.255.775.645; D26.776.708.645; D27.720.280.775.645;

Online Note: use OPHTHALMIC SOLUTIONS to search SOLUTIONS, OPHTHALMIC 1966

History Note: 67; was SOLUTIONS, OPHTHALMIC 1963-66

Technical Notes: sterile solutions for instillation into the eyes: not for solutions for cleaning eyeglass lenses ( = SOLUTIONS + specific type of lens); not for cleaning contact lenses ( = CONTACT LENS SOLUTIONS); D25-26 qualif if IM & GEN; NIM coord with no qualif + specific drug IM; DF: OPHTHALMIC SOL